Correlation of serum cytokine-induced neutrophil chemoattractant levels with Helicobacter pylori infection and disease severity in gastric cancer patients

doi:10.4251/wjgo.v17.i7.105455

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (550)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

HTML

256

Figures (1-5)

Tables (1-4)

Sum=410

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=112

Jul 15, 2025 (publication date) through Aug 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jul 15, 2025; 17(7): 105455
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.105455

Full Size Figure Download Figure

Figure 4 Serum cytokine-induced neutrophil chemoattractant levels classified according to gastric cancer subtype. ^aP < 0.05, ^bP < 0.01 for Helicobacter pylori (H. pylori)-positive vs H. pylori-negative within each subtype; CINC: Cytokine-induced neutrophil chemoattractant; H. pylori: Helicobacter pylori.

Citation: Zhang HL, Niu XL, Wang N. Correlation of serum cytokine-induced neutrophil chemoattractant levels with Helicobacter pylori infection and disease severity in gastric cancer patients. World J Gastrointest Oncol 2025; 17(7): 105455
URL: https://www.wjgnet.com/1948-5204/full/v17/i7/105455.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.105455